Gastrimmune

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2007
01219952007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
G17DT (Gastrimmune) is an antigastrin-17 immunogen, raising antibodies that blockade gastrin-stimulated tumor growth. It has… (More)
Is this relevant?
2001
2001
Serum hypergastrinemia promotes the growth of colorectal adenocarcinoma. Some colorectal adenomas express cholecystokinin B… (More)
Is this relevant?
2001
2001
BACKGROUND Gastrimmune is an immunogenic form of gastrin. It raises in situ antibodies against two proliferative forms of gastrin… (More)
Is this relevant?
2000
2000
Gastrin is a growth factor for colorectal cancer, and therefore, anti-gastrin hormone therapy has a potential role in treatment… (More)
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
1999
1999
Both precursor forms of gastrin and mature amidated gastrin peptides can enhance proliferation of colorectal tumours and may… (More)
Is this relevant?
1999
1999
BACKGROUND Gastrin is a growth factor for established tumours. AIMS To investigate the therapeutic effect of antibodies, raised… (More)
Is this relevant?
1999
1999
The therapeutic effect of antibodies raised by the immunogen Gastrimmune was compared with both a CCKB/gastrin receptor… (More)
Is this relevant?
1998
1998
Mature and post-translational precursor gastrin forms are growth factors for colorectal tumours. The immunogen Gastrimmune is… (More)
Is this relevant?
1996
1996
The effect of gastrin neutralization was evaluated on the in vivo growth of the rat colon line, DHDK12, which expressed… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1995
1995
The neutralising ability of rabbit anti-gastrin-17 (G17) antiserum raised by Gastrimmune, an immunogen constructed of the N… (More)
Is this relevant?